全文获取类型
收费全文 | 4003篇 |
免费 | 391篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 133篇 |
妇产科学 | 56篇 |
基础医学 | 449篇 |
口腔科学 | 177篇 |
临床医学 | 363篇 |
内科学 | 683篇 |
皮肤病学 | 38篇 |
神经病学 | 459篇 |
特种医学 | 244篇 |
外科学 | 411篇 |
综合类 | 179篇 |
一般理论 | 1篇 |
预防医学 | 334篇 |
眼科学 | 82篇 |
药学 | 335篇 |
中国医学 | 40篇 |
肿瘤学 | 371篇 |
出版年
2022年 | 36篇 |
2021年 | 58篇 |
2020年 | 43篇 |
2019年 | 54篇 |
2018年 | 63篇 |
2017年 | 38篇 |
2016年 | 61篇 |
2015年 | 63篇 |
2014年 | 114篇 |
2013年 | 132篇 |
2012年 | 197篇 |
2011年 | 169篇 |
2010年 | 153篇 |
2009年 | 122篇 |
2008年 | 174篇 |
2007年 | 173篇 |
2006年 | 199篇 |
2005年 | 171篇 |
2004年 | 163篇 |
2003年 | 149篇 |
2002年 | 133篇 |
2001年 | 141篇 |
2000年 | 111篇 |
1999年 | 110篇 |
1998年 | 79篇 |
1997年 | 84篇 |
1996年 | 72篇 |
1995年 | 68篇 |
1994年 | 60篇 |
1993年 | 49篇 |
1992年 | 68篇 |
1991年 | 71篇 |
1990年 | 68篇 |
1989年 | 78篇 |
1988年 | 77篇 |
1987年 | 82篇 |
1986年 | 75篇 |
1985年 | 54篇 |
1984年 | 53篇 |
1983年 | 39篇 |
1982年 | 35篇 |
1979年 | 34篇 |
1978年 | 37篇 |
1977年 | 36篇 |
1976年 | 27篇 |
1975年 | 24篇 |
1974年 | 25篇 |
1971年 | 24篇 |
1970年 | 34篇 |
1969年 | 22篇 |
排序方式: 共有4412条查询结果,搜索用时 15 毫秒
131.
132.
Jeffrey M. Hardacre Mary Mulcahy William Small Mark Talamonti Jennifer Obel Smitha Krishnamurthi Caio S. Rocha-Lima Howard Safran Heinz-Joseph Lenz E. Gabriela Chiorean 《Journal of gastrointestinal surgery》2013,17(1):94-101
Background
Despite continued investigation, limited progress has been made in the adjuvant treatment of resected pancreatic cancer. Novel or targeted therapies are needed.Methods
Multi-institutional, open-label, dose-finding, phase 2 trial evaluating the use of algenpantucel-L (NewLink Genetics Corporation, Ames, IA) immunotherapy in addition to chemotherapy and chemoradiotherapy in the adjuvant setting for resected pancreatic cancer (ClinicalTrials.gov identifier, NCT00569387). The primary outcome was 12-month disease-free survival. Secondary outcomes included overall survival and toxicity.Results
Seventy patients were treated with gemcitabine and 5-fluorouracil-based chemoradiotherapy as well as algenpantucel-L (mean 12 doses, range 1–14). After a median follow-up of 21 months, the 12-month disease-free survival was 62 %, and the 12-month overall survival was 86 %. The most common adverse events were injection site pain and induration.Conclusions
The addition of algenpantucel-L to standard adjuvant therapy for resected pancreatic cancer may improve survival. A multi-institutional, phase 3 study is ongoing (ClinicalTrials.gov identifier, NCT01072981). 相似文献133.
Malcolm R. McNeil Patrick J. Doyle Kristie Spencer Amy Jackson Goda Diane Flores Steven L. Small 《Aphasiology》2013,27(7-8):575-585
Abstract A study by McNeil et al. reported no generalization effects in two individuals with aphasia following application of a word finding treatment in which subjects were trained sequentially on lexical items arranged by form class. The present investigation examined, in one of the two subjects from the original study, whether training on lexical items from a variety of form classes concurrently would result in greater response generalization than was observed previously in this subject. Results replicated earlier findings with positive acquisition and maintenance effects and little evidence of generalization to untrained items within or across form classes. 相似文献
134.
135.
136.
137.
摘要:目的 探讨白花蛇舌草-半枝莲药对组分对结肠腺癌Lovo细胞增殖、侵袭、迁移和凋亡的影响及作用机制。方法 将白花蛇舌草、半枝莲按质量1∶1进行3次煎煮,获得水提物,后取适量浸膏用石油醚回流脱脂,再以乙酸乙酯进行多次萃取,获得白花蛇舌草-半枝莲药对组分,并计算得率。实验分为对照组(正常培养Lovo细胞)、白花蛇舌草-半枝莲药对组分低剂量组(10 mg/L)、中剂量组(30 mg/L)及高剂量组(50 mg/L)。通过噻唑蓝比色法(MTT)检测各组细胞培养24、48、72 h后的增殖抑制率。各组细胞培养48 h后,流式细胞仪检测细胞周期分布;Transwell实验检测细胞侵袭能力;划痕实验检测细胞迁移能力;TUNEL法检测细胞凋亡情况;Western blot法检测Grb2相关结合蛋白1(Gab1)、血管内皮生长因子受体2(VEGFR-2)、磷脂酰肌醇3-激酶(PI3K)、苏氨酸激酶(Akt)、基质金属蛋白酶-9(MMP-9)、B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2相关X蛋白(Bax)蛋白表达情况。结果 化学萃取后的白花蛇舌草-半枝莲药对中主要含有对羟基苯乙酮、野黄芩苷、木犀草素和芹菜素4种化合物,组分得率为0.61%。与对照组相比,低、中、高剂量组细胞增殖抑制率升高,G1期肿瘤细胞比例增加,细胞凋亡指数增高,侵袭细胞数和划痕闭合率明显减小(均P<0.05),细胞中Gab1、VEGFR-2、PI3K、Akt、MMP-9、Bcl-2蛋白表达降低,Bax表达升高(均P<0.05),且存在剂量依赖性。结论 白花蛇舌草-半枝莲药对组分可抑制结肠腺癌Lovo细胞的增殖,降低其迁移和侵袭能力,诱导细胞凋亡,其机制可能与抑制Gab1/VEGFR-2/PI3K/Akt信号通路活化有关。 相似文献
138.
139.
Pneumothoraces are a possible sequela of chest trauma with potential morbidity and mortality if not recognized and treated promptly. A portable supine chest radiograph is frequently the first radiologic study performed in the setting of trauma. While large pneumothoraces can be readily recognized on these radiographs, smaller pneumothoraces are missed in up to 15 % of trauma patients. There are many radiographic signs of occult pneumothoraces, and we are presenting a new radiographic sign of occult pneumothorax. The floating cardiac fat pad sign occurs when pleural air collects anteriorly and superiorly in the most non-dependent portion of the chest lifting the pericardial fat pad off the diaphragm. Lung markings are still seen surrounding the pericardial fat pad due to the inflated lower lobe of the lung resting dependently. Rapid and accurate identification of pneumothoraces is critical but often difficult on chest radiographs. Although there are many existing radiographic signs for identification of pneumothorax, prospective identification of small pneumothoraces is still relatively poor. Here, we describe an additional sign which aides in the detection of pneumothoraces, the floating cardiac fat pad. When present, this should prompt further evaluation with chest CT or upright chest radiograph. 相似文献
140.
Robert J Ellis David M Small David A Vesey David W Johnson Ross Francis Luis Vitetta Glenda C Gobe Christudas Morais 《Nephrology (Carlton, Vic.)》2016,21(3):170-177
In the last decade, chronic kidney disease (CKD), defined as reduced renal function (glomerular filtration rate (GFR) < 60 mL/min per 1.73 m2) and/or evidence of kidney damage (typically manifested as albuminuria) for at least 3 months, has become one of the fastest‐growing public health concerns worldwide. CKD is characterized by reduced clearance and increased serum accumulation of metabolic waste products (uremic retention solutes). At least 152 uremic retention solutes have been reported. This review focuses on indoxyl sulphate (IS), a protein‐bound, tryptophan‐derived metabolite that is generated by intestinal micro‐organisms (microbiota). Animal studies have demonstrated an association between IS accumulation and increased fibrosis, and oxidative stress. This has been mirrored by in vitro studies, many of which report cytotoxic effects in kidney proximal tubular cells following IS exposure. Clinical studies have associated IS accumulation with deleterious effects, such as kidney functional decline and adverse cardiovascular events, although causality has not been conclusively established. The aims of this review are to: (i) establish factors associated with increased serum accumulation of IS; (ii) report effects of IS accumulation in clinical studies; (iii) critique the reported effects of IS in the kidney, when administered both in vivo and in vitro; and (iv) summarize both established and hypothetical therapeutic options for reducing serum IS or antagonizing its reported downstream effects in the kidney. 相似文献